Key result
Administration of the CaMKII inhibitor KN-93 before global ischaemia reduced reperfusion-induced arrhythmias and improved post-ischaemic contractile recovery in isolated rat hearts.
Why the study?
Does KN-93 reduce reperfusion-induced arrhythmias and improve contractile recovery in isolated rat hearts subjected to ischaemia-reperfusion?
Does KN-93 reduce reperfusion-induced arrhythmias and improve contractile recovery in isolated rat hearts subjected to ischaemia-reperfusion?
Inhibition of CaMKII with KN-93 reduces reperfusion-induced arrhythmias and improves contractile recovery in rat hearts, likely by regulating CaMKIIδ turnover and NCX1 expression.
Supports CaMKII inhibition in ischaemia-reperfusion; hypothesis-generating in animals, clinical translation unknown.
Although Ca(2+)/calmodulin-dependent protein kinase II delta (CaMKIIδ) has been implicated in development of different phenotypes of myocardial ischaemia-reperfusion injury, its involvement in arrhythmogenesis and cardiac stunning is not sufficiently elucidated. Moreover, the mechanisms by which CaMKIIδ mediates disturbances in excitation-contraction coupling, are not exactly known. To investigate this, KN-93 (0.5 µmol/L), a CaMKII inhibitor, was administered before induction of global ischaemia and reperfusion in isolated Langendorff-perfused rat hearts. Expression of CaMKIIδ and the sarcollemal Ca(2+)-cycling proteins, known to be activated during reperfusion, was analyzed using immunoblotting. KN-93 reduced reperfusion-induced ectopic activity and the incidence of ventricular fibrillation. Likewise, the severity of arrhythmias was lower in KN-treated hearts. During the pre-ischaemia phase, neither inotropic nor chronotropic effects were elicited by KN-93, whereas post-ischaemic contractile recovery was significantly improved. Ischaemia-reperfusion increased the expression of CaMKIIδ and sodium-calcium exchanger (NCX1) proteins without any influence on the protein content of alpha 1c, a pore-forming subunit of L-type calcium channels (LTCCs). On the other hand, inhibition of CaMKII normalized changes in the expression of CaMKIIδ and NCX1. Taken together, CaMKIIδ seems to regulate its own turnover and to be an important component of cascade integrating NCX1, rather than LTCCs that promote ischaemia-reperfusion-induced contractile dysfunction and arrhythmias.
No takes yet. Share an insight, caveat, or question.
Adameová et al. (2012) studied Myocardial ischaemia-reperfusion injury. KN-93 was evaluated on Reperfusion-induced ectopic activity, incidence of ventricular fibrillation, and post-ischaemic contractile recovery. Administration of the CaMKII inhibitor KN-93 before global ischaemia reduced reperfusion-induced arrhythmias and improved post-ischaemic contractile recovery in isolated rat hearts.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: